Vaccine Trials Target Leading Cause of Diarrheal Disease Deaths

Why it matters locally: While a national health issue, diarrheal diseases, including those caused by Shigella, contribute to public health concerns in New York, particularly among vulnerable populations and children. The availability of a new vaccine could reduce the burden on local healthcare systems and improve health outcomes.

Medical researchers are conducting trials for a new vaccine designed to combat Shigella bacteria. Shigella represents a primary cause of diarrheal disease globally. Diarrheal diseases result in over one million deaths each year. Children under the age of five account for nearly half of these fatalities. The development of this vaccine offers a potential intervention against this widespread health issue.